Kurokawa Ichiro, Senba Yuko, Nishimura Keisuke, Habe Koji, Hakamada Arata, Isoda Ken-Ichi, Yamanaka Kei-Ichi, Mizutani Hitoshi, Tsubura Airo
Department of Dermatology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie 514-8507, Japan.
In Vivo. 2006 Sep-Oct;20(5):583-5.
An immunohistochemical study of cytokeratins (CK) in a case of trichilemmal carcinoma (TLC). CK expression showed the presence of CK 1, 10, 14 and 17, suggesting that TLC differentiates toward follicular infundibulum. In a comparison of CK expression between TLC and trichilemmoma, the absence of CK 15 and 16 in TLC may be related to transformation from trichilemmoma to TLC. Trichilemmal carcinoma (TLC) is a rare cutaneous tumor, and is considered as a malignant counterpart of trichilemmoma. The histogenesis of TLC remains unclear. The features of TLC resemble the outer root sheath. Monoclonal antibodies against cytokeratin (CK) are crucial markers for evaluating the origin of epithelial tumors and the stage of differentiation. To elucidate the origin and the stage of differentiation of TLC, an immunohistochemical study of CK was performed using nine different anti-keratin antibodies against CK1, 7, 8, 10,14,16,17, 18 and 19.
一例毛鞘癌(TLC)的细胞角蛋白(CK)免疫组织化学研究。CK表达显示存在CK 1、10、14和17,提示TLC向毛囊漏斗部分化。在TLC与毛鞘瘤之间的CK表达比较中,TLC中缺乏CK 15和16可能与毛鞘瘤向TLC的转变有关。毛鞘癌(TLC)是一种罕见的皮肤肿瘤,被认为是毛鞘瘤的恶性对应物。TLC的组织发生仍不清楚。TLC的特征类似于外根鞘。抗细胞角蛋白(CK)单克隆抗体是评估上皮肿瘤起源和分化阶段的关键标志物。为阐明TLC的起源和分化阶段,使用9种不同的抗角蛋白抗体(针对CK1、7、8、10、14、16、17、18和19)对CK进行了免疫组织化学研究。